Company type | Public |
---|---|
Industry | Pharmaceutical |
Founded | 1952 |
Headquarters | Parsippany, New Jersey, U.S. |
Area served | Worldwide |
Key people |
|
Revenue | US$8.54 billion (2023) |
US$3.02 billion (2023) | |
US$2.34 billion (2023) | |
Total assets | US$14.3 billion (2023) |
Total equity | US$4.99 billion (2023) |
Number of employees | c. 14,100 (2023) |
Website | zoetis |
Footnotes / references [2][3] |
Zoetis Inc. (/zō-EH-tis/[4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.[5][4][6] The company was a subsidiary of Pfizer,[7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries.[8] Operations outside the United States accounted for 50% of the total revenue.[5] Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.[9]
:0
was invoked but never defined (see the help page).